Key Highlights
- Veeva Systems finished among the S&P 500's weaker names on Friday, with no company-specific news found, as health care was the only one of 11 sectors to close in the red.
- Drug distributors Cardinal Health, McKesson and Cencora all fell alongside MedTech maker Boston Scientific and biotech Alnylam, extending weakness from Thursday when life-science tools makers Danaher and Thermo Fisher were under pressure.
- The day's rally was centered on hardware rather than software: chipmakers and AI server makers surged while design-software maker Cadence and Adobe slipped, leaving Veeva, classified as health care but trading like software, without a clear home.
- Treasury yields reversed to close higher after the jobs report, a Factor that can weigh on high-valuation software firms whose value depends heavily on profits expected years in the future.
Veeva Systems (NYSE:VEEV) sells cloud software built specifically for the life sciences industry. Drugmakers and biotech firms use its tools to manage clinical trials, regulatory filings, quality records and sales and Marketing to doctors. That makes it a technology company whose fortunes are tied closely to the health of the pharmaceutical business. Shares slipped on Friday, finishing among the S&P 500's weaker names as health care became the only sector in the index to close in the red. No company-specific news on Veeva was found for the session.
Stuck Between Two Worlds
Veeva's position is unusual. It is classified in health care, but it trades much like a software stock. On Friday, neither label helped.
Health care was the only one of the 11 S&P 500 sectors to finish lower, though its dip was slight. Drug distributors Cardinal Health, McKesson and Cencora all fell, and medtech maker Boston Scientific and biotech Alnylam also ended lower. The weakness extended a soft patch from Thursday, when life-science tools makers such as Danaher and Thermo Fisher were under pressure. Those companies sell equipment to the same drug and biotech customers that Veeva serves.
Meanwhile, the technology rally that lifted the market was centred on hardware rather than software. Chipmakers such as Teradyne, Monolithic Power and Texas Instruments surged, and AI server makers HPE, Super Micro and Dell climbed. Several software and services names, including design-software maker Cadence and Adobe, slipped.
A Jobs Report That Moved Everything
The big catalyst for markets came early. The Labor Department said US employers added just 29,000 jobs in September, against forecasts of roughly 84,000. Revisions cut a combined 60,000 jobs from July and August, and the Unemployment rate ticked up.
The soft numbers lowered the chance of another Federal Reserve rate hike. The Fed under Chair Kevin Warsh raised rates on September 16, the first increase since 2023, after the oil shock from the US-Israel war with Iran pushed Inflation higher. After Friday's report, odds of a hike at the October 27-28 meeting dropped to roughly one in five.
That lifted the major indexes. The S&P 500 rose 56.27 points to 7,722.72, the Nasdaq Composite gained 319.27 points and the Nasdaq-100 notched a record close.
But the rally was narrow. Only about one in five S&P 500 stocks traded above their 50-day moving averages, meaning many companies did not share in the gains.
The Rate Backdrop for Software
High-valuation software firms are usually sensitive to bond yields because their value depends heavily on profits expected years in the future. Yields fell immediately after the jobs data but reversed to close higher, with the 10-year near its highest level since 2002. That late shift may have tempered enthusiasm for some growth names outside the chip space.
A Sector and Style Move, Not a Company Story
Veeva's customers are drug and biotech companies, so health care sentiment will continue to shape the stock. Investors will watch whether the sector can recover after two soft sessions.
The Fed's October 27-28 meeting remains the major macro event on the calendar. Before then, Earnings season gets under way with PepsiCo on October 8 and Delta on October 9, followed by the big banks on October 13 and 14. Analysts expect strong double-digit earnings growth for the S&P 500 in the third quarter.
For now, Veeva's dip looked like a sector and style move rather than a reaction to anything the company did or said.






Please wait processing your request...